What is Lifevantage Corporation's earnings per share (EPS)?

Lifevantage Corporation (LFVN) reported diluted earnings per share of $0.40 for fiscal year 2026. This represents a -46.7% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Lifevantage Corporation (LFVN) Financials

LFVN

FY2026 annual

Revenue $182.6M -20.1% YoY

Net Income $5.1M -48.3% YoY

EPS (Diluted) $0.40 -46.7% YoY

Free Cash Flow $6.7M -36.5% YoY

Market Cap $73.0M as of Oct 15, 2026

Price / Sales 0.4x on $182.6M revenue, FY2026

Price / Earnings 14.4x on $5.1M net income, FY2026

Price / Book 2.2x on $33.6M equity, Q4 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 15, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period FY2026, ended Jun 30, 2026 Reported Aug 27, 2026 Currency USD FYE June

Newest figures come from the 10-K for FY2026, filed Aug 27, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the LFVN SEC filings page.

Lifevantage Corporation (LFVN) reported $182.6M in revenue for fiscal year 2026, down 20.1% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI LFVN FY2026 2026-10-03

FY2026 shows a smaller, less profitable sales base, but cash generation and lower liabilities keep the balance sheet comparatively flexible.

Revenue fell 20.1% in FY2026 while operating margin narrowed 2.0 points, indicating the downturn hit profitability beyond volume alone. Operating cash flow of $10.2M converted into $6.7M of free cash flow after reinvestment, showing the business produced cash beyond accounting profit.

Liabilities fell 23.5% from FY2025 while debt-to-equity moved to 0.8x, meaning the sales contraction came with a less burdened capital structure rather than added leverage. A 1.9x current ratio alongside lower liabilities suggests short-term coverage remained intact.

SG&A fell 15.6% in FY2026, but operating margin still compressed by 2.0 points, so expense reduction only partly offset weaker gross economics. Gross margin slipped 2.8 points and net margin settled at 2.8%; the FY2025 profit improvement therefore did not become a stable margin structure.

Financial Health Signals

Financial Health Score 49/100

Scored against operating companies for FY2026. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Lifevantage Corporation's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Lifevantage Corporation has an operating margin of 3.3%, meaning the company retains $3 of operating profit per $100 of revenue. This results in a moderate score of 51/100, indicating healthy but not exceptional operating efficiency. This is down from 5.3% the prior year.

Growth

Lifevantage Corporation's revenue declined 20.1% year-over-year, from $228.5M to $182.6M. This contraction results in a growth score of 18/100.

Leverage

Lifevantage Corporation has a moderate D/E ratio of 0.85. This balance of debt and equity financing earns a leverage score of 51/100.

Liquidity

Lifevantage Corporation's current ratio of 1.89 indicates adequate short-term liquidity, earning a score of 56/100. The company can meet its near-term obligations, though with limited headroom.

Cash Flow

Lifevantage Corporation has a free cash flow margin of 3.6%, earning a moderate score of 42/100. The company generates positive cash flow after capital investments, but with room for improvement.

Returns

Lifevantage Corporation earns a strong 15.1% return on equity (ROE), meaning it generates $15 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 78/100. This is down from 28.3% the prior year.

Altman Z-Score Grey Zone

2.82

Lifevantage Corporation scores 2.82, placing it in the grey zone between 1.81 and 2.99. The score is driven primarily by a large market capitalization ($73.0M) relative to total liabilities ($28.5M). This signals moderate financial risk that warrants monitoring.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial

5/8

Lifevantage Corporation passes 5 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 3 of 4 profitability signals pass, all 2 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Cash-Backed

2.02x

For every $1 of reported earnings, Lifevantage Corporation generates $2.02 in operating cash flow ($10.2M OCF vs $5.1M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$42.4M

YoY-23.1%

QoQ-3.1%

5Y CAGR-5.0%

10Y CAGR-2.2%

Lifevantage Corporation generated $42.4M in revenue in Q4 2026. This represents a decrease of 23.1% from the same quarter a year earlier. Against the prior quarter it is down 3.1%.

EBITDA

$2.4M

YoY-18.4%

QoQ-1.2%

Lifevantage Corporation's EBITDA was $2.4M in Q4 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 18.4% from the same quarter a year earlier. Against the prior quarter it is down 1.2%.

Net Income

$1.3M

YoY-34.7%

QoQ-6.1%

5Y CAGR-23.6%

10Y CAGR-6.2%

Lifevantage Corporation reported $1.3M in net income in Q4 2026. This represents a decrease of 34.7% from the same quarter a year earlier. Against the prior quarter it is down 6.1%.

EPS (Diluted)

$0.10

YoY-33.3%

QoQ-9.1%

5Y CAGR-22.2%

10Y CAGR-5.2%

Lifevantage Corporation earned $0.10 per diluted share (EPS) in Q4 2026. This represents a decrease of 33.3% from the same quarter a year earlier. Against the prior quarter it is down 9.1%.

Cash & Balance Sheet

Free Cash Flow

$3.7M

YoY+346.7%

QoQ-6.2%

5Y CAGR-13.9%

Lifevantage Corporation generated $3.7M in free cash flow in Q4 2026, representing cash available after capex. This represents an increase of 346.7% from the same quarter a year earlier. Against the prior quarter it is down 6.2%.

Cash & Debt

$14.9M

YoY-26.1%

QoQ+19.5%

5Y CAGR-8.4%

10Y CAGR+6.6%

Lifevantage Corporation held $14.9M in cash as of Q4 2026; long-term debt is not reported for that period.

Dividends Per Share

$0.05

YoY+11.1%

QoQ+11.1%

Lifevantage Corporation paid $0.05 per share in dividends in Q4 2026. This represents an increase of 11.1% from the same quarter a year earlier. Against the prior quarter it is up 11.1%.

Shares Outstanding

13M

YoY-1.3%

QoQ-0.7%

5Y CAGR-1.7%

10Y CAGR-1.1%

Lifevantage Corporation had 13M shares outstanding in Q4 2026. This represents a decrease of 1.3% from the same quarter a year earlier. Against the prior quarter it is down 0.7%.

Margins & Returns

Gross Margin

78.0%

YoY-2.0pp

QoQ-1.1pp

5Y change-4.2pp

10Y change-4.3pp

Lifevantage Corporation's gross margin was 78.0% in Q4 2026, indicating the percentage of revenue retained after direct costs. This is down 2.0 percentage points from the same quarter a year earlier. Against the prior quarter it is down 1.1 percentage points.

Operating Margin

3.9%

YoY0.0pp

QoQ+0.1pp

Lifevantage Corporation's operating margin was 3.9% in Q4 2026, reflecting core business profitability. That is unchanged from the same quarter a year earlier. Against the prior quarter it is up 0.1 percentage points.

Net Margin

3.0%

YoY-0.5pp

QoQ-0.1pp

5Y change-5.9pp

10Y change-1.6pp

Lifevantage Corporation's net profit margin was 3.0% in Q4 2026, showing the share of revenue converted to profit. This is down 0.5 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.1 percentage points.

Return on Equity

3.8%

YoY-1.8pp

QoQ-0.3pp

5Y change-9.5pp

10Y change-19.1pp

Lifevantage Corporation's ROE was 3.8% in Q4 2026, measuring profit generated per dollar of shareholder equity. This is down 1.8 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.3 percentage points.

Capital Allocation

R&D Spending

$300K

YoY-40.0%

QoQ+50.0%

Lifevantage Corporation invested $300K in research and development in Q4 2026. This represents a decrease of 40.0% from the same quarter a year earlier. Against the prior quarter it is up 50.0%.

Share Buybacks

$460K

YoY-77.4%

QoQ-54.3%

5Y CAGR-34.9%

Lifevantage Corporation spent $460K on share buybacks in Q4 2026, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 77.4% from the same quarter a year earlier. Against the prior quarter it is down 54.3%.

Capital Expenditures

$1.0M

YoY+421.1%

QoQ+2.6%

5Y CAGR+16.7%

10Y CAGR+32.3%

Lifevantage Corporation invested $1.0M in capex in Q4 2026, funding long-term assets and infrastructure. This represents an increase of 421.1% from the same quarter a year earlier. Against the prior quarter it is up 2.6%.

LFVN Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

LFVN quarterly income statement

Metric	FY2610-K	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K
Revenue	$182.6M-20.1%	$228.5M+14.2%	$200.2M-6.2%	$213.4M+3.4%	$206.4M-6.3%	$220.2M-5.5%	$232.9M+3.1%	$226.0M+11.2%	$203.2M+1.9%	$199.5M-3.4%	$206.5M+8.5%	$190.3M-11.0%	$214.0M+2.8%	$208.2M+65.0%	$126.2M
Cost of Revenue	$41.0M-8.7%	$44.9M+8.3%	$41.4M-4.5%	$43.4M+13.9%	$38.1M-0.2%	$38.2M+0.6%	$38.0M0.0%	$38.0M+9.0%	$34.8M+4.2%	$33.5M-1.4%	$33.9M+21.1%	$28.0M-15.6%	$33.2M+4.2%	$31.8M+76.4%	$18.1M
Gross Profit	$141.6M-22.9%	$183.7M+15.7%	$158.7M-6.6%	$170.0M+1.0%	$168.3M-7.5%	$182.0M-6.6%	$195.0M+3.7%	$188.0M+11.7%	$168.4M+1.4%	$166.0M-3.8%	$172.6M+6.3%	$162.3M-10.2%	$180.8M+5.4%	$171.5M+58.6%	$108.1M
R&D Expenses	$1.0M-28.6%	$1.4M+100.0%	$700K+16.7%	$600K-14.3%	$700K0.0%	$700K-22.2%	$900K-18.2%	$1.1M-8.3%	$1.2M+9.1%	$1.1M+10.0%	$1.0M-58.3%	$2.4M+20.0%	$2.0M-31.0%	$2.9M+107.1%	$1.4M
SG&A Expenses	$58.4M-15.6%	$69.2M+1.1%	$68.5M-3.6%	$71.1M+12.0%	$63.4M+4.3%	$60.8M-10.4%	$67.9M-2.4%	$69.6M+16.2%	$59.8M-7.8%	$64.9M+15.8%	$56.1M-2.2%	$57.4M+1.0%	$56.8M-1.6%	$57.7M+101.0%	$28.7M
Operating Income	$6.1M-50.0%	$12.2M+181.6%	$4.3M+1.7%	$4.3M-43.8%	$7.6M-57.0%	$17.6M+13.9%	$15.5M+57.6%	$9.8M-4.9%	$10.3M+132.0%	$4.4M-66.8%	$13.4M-3.5%	$13.9M-28.5%	$19.4M+61.2%	$12.1M-43.8%	$21.5M
EBITDA	$8.9M-42.2%	$15.4M+94.0%	$7.9M+1.0%	$7.8M-27.7%	$10.8M-48.6%	$21.1M+15.5%	$18.2M+55.8%	$11.7M+0.5%	$11.6M+91.2%	$6.1M-60.2%	$15.3M-5.4%	$16.2M-25.0%	$21.6M+57.1%	$13.7M-37.5%	$22.0M
Interest Expense	N/A	N/A	-$430K-117.2%	-$198K-2080.0%	$10K-41.2%	$17K-85.8%	$120K-62.8%	$323K-29.2%	$456K-20.0%	$570K-82.8%	$3.3M+7.6%	$3.1M-2.8%	$3.2M+105800.0%	$3K-62.5%	$8K
Income Tax	$994K-59.2%	$2.4M+72.5%	$1.4M-3.2%	$1.5M-7.1%	$1.6M-63.8%	$4.3M+39.4%	$3.1M+72.8%	$1.8M-52.4%	$3.8M+190.9%	$1.3M-49.5%	$2.6M-26.9%	$3.5M-33.1%	$5.3M+48.7%	$3.5M+60.9%	$2.2M
Net Income	$5.1M-48.3%	$9.8M+233.8%	$2.9M+15.6%	$2.5M-18.6%	$3.1M-75.8%	$12.9M+11.6%	$11.5M+55.5%	$7.4M+29.0%	$5.8M+258.3%	$1.6M-73.7%	$6.1M-14.3%	$7.1M-37.4%	$11.4M+49.6%	$7.6M-39.0%	$12.5M
EPS (Basic)	$0.40-50.0%	$0.80+233.3%	$0.24+20.0%	$0.20-16.7%	$0.24-73.9%	$0.92+12.2%	$0.82+54.7%	$0.53+29.3%	$0.41+241.7%	$0.12-72.7%	$0.44-13.7%	$0.51-32.0%	$0.75+971.4%	$0.07-41.7%	$0.12
EPS (Diluted)	$0.40-46.7%	$0.75+226.1%	$0.23+15.0%	$0.20-16.7%	$0.24-73.3%	$0.90+13.9%	$0.79+58.0%	$0.50+22.0%	$0.41+272.7%	$0.11-73.8%	$0.42	$0.50-29.6%	$0.71	$0.06-45.5%	$0.11
Diluted Shares (Avg)	13M-2.2%	13M0.0%	13M+3.3%	13M-3.8%	13M-8.4%	14M-2.3%	15M-2.5%	15M+6.0%	14M+0.1%	14M-2.8%	15M	14M-11.2%	16M	123M+3.9%	118M

Metric	Q4'2610-K	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q
Revenue	$42.4M-23.1%	$43.7M-25.2%	$48.9M-27.8%	$47.6M+0.7%	$55.1M+12.6%	$58.4M+21.1%	$67.8M+31.3%	$47.2M-8.1%
Cost of Revenue	$9.3M-15.6%	$9.2M-17.5%	$12.7M-3.6%	$9.7M+2.7%	$11.1M+10.4%	$11.1M+9.3%	$13.2M+19.2%	$9.5M-6.8%
Gross Profit	$33.0M-25.0%	$34.5M-27.0%	$36.2M-33.6%	$37.8M+0.2%	$44.0M+13.2%	$47.3M+24.3%	$54.6M+34.5%	$37.7M-8.4%
R&D Expenses	$300K-40.0%	$200K-50.0%	$200K0.0%	$300K0.0%	$500K+150.0%	$400K+100.0%	$200K+100.0%	$300K+50.0%
SG&A Expenses	$13.9M-25.7%	$13.9M-18.8%	$15.8M-15.0%	$14.9M0.0%	$18.7M+33.2%	$17.1M+3.9%	$18.6M-7.2%	$14.8M-17.3%
Operating Income	$1.7M-22.4%	$1.7M-58.6%	$487K-85.8%	$2.3M-11.8%	$2.1M-26.2%	$4.1M+109.6%	$3.4M+371.8%	$2.6M+243.1%
EBITDA	$2.4M-18.4%	$2.4M-50.7%	$1.2M-70.7%	$2.9M-14.5%	$2.9M-22.0%	$4.9M+71.7%	$4.2M+1516.1%	$3.4M+102.0%
Income Tax	$417K-4.6%	$294K-58.6%	$197K-63.5%	$86K-88.6%	$437K-68.9%	$710K+171.0%	$539K+218.2%	$752K+276.0%
Net Income	$1.3M-34.7%	$1.4M-60.7%	$276K-89.2%	$2.2M+18.0%	$2.0M+50.1%	$3.5M+109.2%	$2.5M+488.7%	$1.8M+190.3%
EPS (Basic)	$0.10-37.5%	$0.11-60.7%	$0.02-90.5%	$0.17+13.3%	$0.16+45.5%	$0.28+115.4%	$0.21+520.0%	$0.15+200.0%
EPS (Diluted)	$0.10-33.3%	$0.11-57.7%	$0.02-89.5%	$0.17+21.4%	$0.15+50.0%	$0.26+100.0%	$0.19+480.0%	$0.14+180.0%
Diluted Shares (Avg)	N/A	13M-4.8%	13M-3.3%	13M+1.0%	N/A	13M+2.4%	13M+4.5%	13M-2.2%

Not reported in any period shown, so not listed: Interest Expense.

LFVN Balance Sheet

LFVN quarterly balance sheet

Metric	FY2610-K	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K
Total Assets	$62.1M-13.7%	$72.0M+19.3%	$60.3M-8.8%	$66.1M-6.5%	$70.7M-10.2%	$78.7M+33.7%	$58.9M+6.5%	$55.3M+8.1%	$51.1M+13.0%	$45.2M-11.0%	$50.9M+27.8%	$39.8M-26.3%	$54.0M-2.7%	$55.5M+24.6%	$44.5M
Current Assets	$38.3M-24.8%	$50.9M+35.2%	$37.6M-15.0%	$44.3M-5.7%	$47.0M-2.3%	$48.1M+9.5%	$43.9M+1.6%	$43.2M+10.9%	$38.9M+9.5%	$35.5M-17.5%	$43.1M+41.5%	$30.5M-23.8%	$40.0M-13.0%	$45.9M+18.3%	$38.8M
Cash & Equivalents	$14.9M-26.1%	$20.2M+19.6%	$16.9M-21.8%	$21.6M+7.0%	$20.2M-12.9%	$23.2M+4.7%	$22.1M+17.6%	$18.8M+13.0%	$16.7M+45.3%	$11.5M+45.4%	$7.9M-43.3%	$13.9M-31.8%	$20.4M-22.5%	$26.3M+6.7%	$24.6M
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	$16.2M-21.8%	$20.7M+37.3%	$15.1M-6.3%	$16.1M-2.4%	$16.5M+2.0%	$16.1M+16.3%	$13.9M+1.0%	$13.8M+0.9%	$13.6M-17.8%	$16.6M-34.0%	$25.1M+171.6%	$9.2M+4.8%	$8.8M-16.1%	$10.5M-7.3%	$11.4M
Accounts Receivable	$3.0M-9.2%	$3.3M+11.7%	$2.9M+82.9%	$1.6M-51.7%	$3.3M+14.1%	$2.9M+12.1%	$2.6M+26.3%	$2.1M0.0%	$2.1M+54.9%	$1.3M-14.0%	$1.6M+50.5%	$1.0M-21.7%	$1.3M-26.4%	$1.8M+437.2%	$333K
Long-Term Investments	$0	$0	$0	$0	$0-100.0%	$2.2M0.0%	$2.2M	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$465K	$0	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$28.5M-23.6%	$37.3M+8.8%	$34.3M+9.0%	$31.5M-19.7%	$39.2M-6.5%	$41.9M+63.6%	$25.6M-8.7%	$28.1M-3.8%	$29.2M-5.0%	$30.7M-23.6%	$40.2M+10.3%	$36.5M-27.1%	$50.0M+132.2%	$21.5M+32.6%	$16.2M
Current Liabilities	$20.2M-25.7%	$27.2M+22.0%	$22.3M+13.8%	$19.6M-23.8%	$25.7M+2.1%	$25.2M+0.7%	$25.0M-4.5%	$26.2M+10.0%	$23.8M+1.9%	$23.4M-23.7%	$30.6M+18.4%	$25.9M+13.9%	$22.7M+10.4%	$20.6M+28.3%	$16.0M
Non-Current Liabilities	$8.3M-17.9%	$10.1M-15.8%	$12.0M+1.1%	$11.9M-11.9%	$13.5M-19.5%	$16.7M+2669.2%	$604K-67.9%	$1.9M-65.1%	$5.4M-26.8%	$7.4M-23.1%	$9.6M-9.6%	$10.6M-61.2%	$27.3M+2706.5%	$973K+348.4%	$217K
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$0-100.0%	$3.4M-37.3%	$5.4M-26.6%	$7.4M-13.2%	$8.5M-66.0%	$25.1M	$0	N/A
Total Equity	$33.6M-3.0%	$34.6M+33.3%	$26.0M-25.0%	$34.6M+9.9%	$31.5M-14.4%	$36.8M+10.7%	$33.3M+22.3%	$27.2M+23.9%	$21.9M+51.1%	$14.5M+36.4%	$10.6M+489.6%	$1.8M-22.6%	$2.3M-93.1%	$33.9M+20.0%	$28.3M
Retained Earnings	-$103.5M+0.7%	-$104.1M+4.2%	-$108.7M-10.6%	-$98.3M+0.1%	-$98.4M-6.6%	-$92.3M+1.0%	-$93.3M+6.7%	-$100.0M+2.7%	-$102.7M+4.0%	-$107.0M+1.5%	-$108.6M+4.8%	-$114.1M-2.6%	-$111.2M-45.5%	-$76.5M+0.6%	-$77.0M

Metric	Q4'2610-K	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q
Total Assets	$62.1M-13.7%	$62.1M-19.6%	$61.2M-10.7%	$61.6M+0.2%	$72.0M+19.3%	$77.2M+26.0%	$68.5M+9.3%	$61.5M-7.7%
Current Assets	$38.3M-24.8%	$39.3M-27.3%	$38.6M-15.8%	$45.0M+16.1%	$50.9M+35.2%	$54.1M+43.2%	$45.8M+18.4%	$38.8M-7.4%
Cash & Equivalents	$14.9M-26.1%	$12.5M-44.4%	$10.2M-52.9%	$13.1M-10.3%	$20.2M+19.6%	$22.5M+29.3%	$21.6M+24.6%	$14.6M-20.7%
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	$16.2M-21.8%	$18.4M-17.3%	$19.0M+8.7%	$20.6M+21.8%	$20.7M+37.3%	$22.2M+46.6%	$17.5M+16.7%	$16.9M+7.7%
Accounts Receivable	$3.0M-9.2%	$2.4M-25.3%	$2.3M+8.1%	$2.4M-18.3%	$3.3M+11.7%	$3.2M+51.8%	$2.1M-10.6%	$3.0M+18.5%
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$465K	$472K	$472K	N/A	$0	N/A	N/A	N/A
Total Liabilities	$28.5M-23.6%	$28.8M-33.4%	$28.2M-27.1%	$28.4M-15.8%	$37.3M+8.8%	$43.2M+25.2%	$38.6M+9.2%	$33.8M-9.5%
Current Liabilities	$20.2M-25.7%	$20.1M-38.3%	$19.0M-31.0%	$18.8M-14.7%	$27.2M+22.0%	$32.6M+45.0%	$27.5M+19.7%	$22.1M-10.6%
Non-Current Liabilities	$8.3M-17.9%	$8.7M-18.4%	$9.2M-17.3%	$9.6M-17.9%	$10.1M-15.8%	$10.6M-11.8%	$11.1M-10.3%	$11.7M-7.3%
Total Equity	$33.6M-3.0%	$33.3M-2.0%	$33.0M+10.4%	$33.2M+19.7%	$34.6M+33.3%	$34.0M+27.1%	$29.9M+9.5%	$27.7M-5.5%
Retained Earnings	-$103.5M+0.7%	-$103.7M-0.1%	-$103.4M+2.9%	-$103.1M+5.0%	-$104.1M+4.2%	-$103.5M+3.9%	-$106.5M+0.5%	-$108.5M-4.3%

Not reported in any period shown, so not listed: Long-Term Debt.

LFVN Cash Flow Statement

LFVN quarterly cash flow statement

Metric	FY2610-K	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K
Operating Cash Flow	$10.2M-13.8%	$11.9M-2.6%	$12.2M+78.6%	$6.8M-14.2%	$8.0M-51.1%	$16.3M-11.2%	$18.3M+3.0%	$17.8M+34.2%	$13.3M+100.9%	$6.6M+9.3%	$6.0M-54.3%	$13.2M+9.2%	$12.1M+13.5%	$10.7M-45.0%	$19.4M
Depreciation & Amortization	$2.8M-12.1%	$3.2M-11.9%	$3.6M+0.1%	$3.6M+9.8%	$3.3M-5.8%	$3.5M+24.6%	$2.8M+46.5%	$1.9M+43.0%	$1.3M-19.4%	$1.6M-13.3%	$1.9M-17.1%	$2.3M+7.9%	$2.1M+27.7%	$1.7M+218.4%	$521K
Stock-Based Compensation	$2.3M-58.9%	$5.7M+73.8%	$3.3M+2.9%	$3.2M+80.3%	$1.8M-13.2%	$2.0M-58.6%	$4.9M-11.0%	$5.5M+72.9%	$3.2M+20.7%	$2.6M+1.0%	$2.6M+45.1%	$1.8M-38.8%	$3.0M+36.1%	$2.2M+63.9%	$1.3M
Capital Expenditures	$3.6M+160.5%	$1.4M-38.9%	$2.2M-26.8%	$3.1M+100.5%	$1.5M-59.1%	$3.7M+39.5%	$2.7M+7.0%	$2.5M-46.1%	$4.6M+340.7%	$1.1M+87.7%	$562K-51.5%	$1.2M-38.9%	$1.9M-62.6%	$5.1M+131.5%	$2.2M
Free Cash Flow	$6.7M-36.5%	$10.5M+5.6%	$10.0M+164.6%	$3.8M-41.5%	$6.4M-48.7%	$12.5M-19.9%	$15.6M+2.4%	$15.3M+77.6%	$8.6M+55.3%	$5.5M+1.2%	$5.5M-54.6%	$12.1M+18.2%	$10.2M+82.9%	$5.6M-67.5%	$17.2M
Investing Cash Flow	-$7.3M-435.0%	-$1.4M+39.1%	-$2.2M+26.6%	-$3.1M-99.9%	-$1.5M+59.0%	-$3.7M-39.3%	-$2.7M+40.5%	-$4.5M+3.1%	-$4.6M-340.7%	-$1.1M-87.7%	-$562K+51.5%	-$1.2M+48.4%	-$2.2M+55.7%	-$5.1M-167.9%	-$1.9M
Financing Cash Flow	-$7.8M-2.4%	-$7.6M+47.3%	-$14.4M-511.7%	-$2.4M+73.7%	-$9.0M+21.8%	-$11.5M+7.8%	-$12.4M-11.7%	-$11.1M-217.8%	-$3.5M-78.7%	-$2.0M+83.3%	-$11.7M+36.6%	-$18.5M-16.8%	-$15.8M-292.8%	-$4.0M-639.3%	$746K
Dividends Paid	$2.3M+13.4%	$2.1M-70.2%	$6.9M+337.6%	$1.6M+319.6%	$378K	$0	$0	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	$2.0M-35.1%	$3.1M-51.1%	$6.4M+682.2%	$822K-90.7%	$8.8M-26.0%	$11.9M+120.8%	$5.4M+16.1%	$4.7M+210.3%	$1.5M	$0	$0-100.0%	$9.8M-78.7%	$46.2M+548.2%	$7.1M+629.8%	$976K

Metric	Q4'2610-K	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q
Operating Cash Flow	$4.8M+361.0%	$5.0M+123.9%	$2.8M-69.7%	-$2.3M-295.4%	$1.0M-60.0%	$2.2M-28.0%	$9.2M+423.6%	-$583K-112.2%
Depreciation & Amortization	$697K-7.1%	$714K-11.1%	$752K-6.7%	$610K-23.5%	$750K-6.9%	$803K-10.3%	$806K-16.2%	$797K-13.2%
Stock-Based Compensation	N/A	$700K-53.3%	$600K-64.7%	$826K-9.9%	N/A	$1.5M+87.5%	$1.7M+112.5%	$917K-6.2%
Capital Expenditures	$1.0M+421.1%	$1.0M+205.4%	$1.1M+120.3%	$439K+25.8%	$199K-28.4%	$331K+13.7%	$492K-9.4%	$349K-69.2%
Free Cash Flow	$3.7M+346.7%	$4.0M+109.6%	$1.7M-80.4%	-$2.7M-194.4%	$835K-63.8%	$1.9M-32.3%	$8.7M+617.2%	-$932K-125.7%
Investing Cash Flow	-$1.0M-421.1%	-$1.0M-205.4%	-$4.8M-881.1%	-$439K-27.2%	-$199K+28.4%	-$331K-13.7%	-$492K+9.4%	-$345K+69.5%
Financing Cash Flow	-$1.1M+64.5%	-$1.6M-41.8%	-$738K+47.3%	-$4.3M-135.1%	-$3.2M-18.3%	-$1.1M+54.3%	-$1.4M+45.0%	-$1.8M+72.6%
Dividends Paid	$625K+11.2%	$573K+13.9%	$575K+14.5%	$571K+14.2%	$562K+11.7%	$503K+12.3%	$502K+10.3%	$500K-91.0%
Share Buybacks	$460K-77.4%	$1.0M	-$1K	$578K-48.1%	$2.0M+11.0%	$0-100.0%	$0-100.0%	$1.1M+40.1%

LFVN Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

LFVN quarterly financial ratios

Metric	FY2610-K	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K
Gross Margin	77.6%-2.8pp	80.4%+1.1pp	79.3%-0.4pp	79.7%-1.9pp	81.5%-1.1pp	82.7%-1.0pp	83.7%+0.5pp	83.2%+0.3pp	82.8%-0.4pp	83.2%-0.3pp	83.6%-1.7pp	85.3%+0.8pp	84.5%+2.1pp	82.4%-3.3pp	85.7%
Operating Margin	3.3%-2.0pp	5.3%+3.2pp	2.2%+0.2pp	2.0%-1.7pp	3.7%-4.3pp	8.0%+1.4pp	6.6%+2.3pp	4.3%-0.7pp	5.1%+2.8pp	2.2%-4.3pp	6.5%-0.8pp	7.3%-1.8pp	9.1%+3.3pp	5.8%-11.2pp	17.0%
Net Margin	2.8%-1.5pp	4.3%+2.8pp	1.5%+0.3pp	1.2%-0.3pp	1.5%-4.3pp	5.9%+0.9pp	5.0%+1.7pp	3.3%+0.4pp	2.8%+2.0pp	0.8%-2.2pp	3.0%-0.8pp	3.7%-1.6pp	5.3%+1.7pp	3.6%-6.2pp	9.9%
Return on Equity	15.1%-13.2pp	28.3%+17.0pp	11.3%+4.0pp	7.3%-2.6pp	9.9%-25.1pp	35.0%+0.3pp	34.7%+7.4pp	27.3%+1.1pp	26.3%+15.2pp	11.1%-46.3pp	57.3%-337.2pp	394.5%-93.4pp	487.9%+465.5pp	22.4%-21.7pp	44.1%
Return on Assets	8.2%-5.5pp	13.6%+8.8pp	4.9%+1.0pp	3.8%-0.6pp	4.4%-12.0pp	16.4%-3.2pp	19.6%+6.2pp	13.4%+2.2pp	11.3%+7.7pp	3.5%-8.5pp	12.0%-5.9pp	17.9%-3.2pp	21.1%+7.4pp	13.7%-14.3pp	28.0%
Current Ratio	1.890.0x	1.87+0.2x	1.69-0.6x	2.26+0.4x	1.83-0.1x	1.91+0.2x	1.75+0.1x	1.650.0x	1.64+0.1x	1.52+0.1x	1.41+0.2x	1.18-0.6x	1.76-0.5x	2.23-0.2x	2.42
Debt-to-Equity	0.85-0.2x	1.08-0.2x	1.32+0.4x	0.91-0.3x	1.24+0.1x	1.14+0.4x	0.77+0.8x	0.00-0.2x	0.16-0.2x	0.37-0.3x	0.70-4.0x	4.72-6.0x	10.75+10.7x	0.00-0.6x	0.57
Asset Turnover	2.94-0.2x	3.18-0.1x	3.32+0.1x	3.23+0.3x	2.92+0.1x	2.80-1.2x	3.96-0.1x	4.09+0.1x	3.97-0.4x	4.41+0.3x	4.06-0.7x	4.78+0.8x	3.96+0.2x	3.75+0.9x	2.83
FCF Margin	3.6%-1.0pp	4.6%-0.4pp	5.0%+3.2pp	1.8%-1.4pp	3.1%-2.6pp	5.7%-1.0pp	6.7%0.0pp	6.8%+2.5pp	4.2%+1.5pp	2.8%+0.1pp	2.6%-3.7pp	6.3%+1.6pp	4.8%+2.1pp	2.7%-10.9pp	13.6%

Metric	Q4'2610-K	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q
Gross Margin	78.0%-2.0pp	79.0%-2.0pp	74.0%-6.5pp	79.5%-0.4pp	79.9%+0.4pp	81.0%+2.1pp	80.5%+2.0pp	79.9%-0.3pp
Operating Margin	3.9%0.0pp	3.8%-3.1pp	1.0%-4.1pp	4.8%-0.7pp	3.9%-2.0pp	6.9%+2.9pp	5.1%+7.5pp	5.4%+4.0pp
Net Margin	3.0%-0.5pp	3.1%-2.8pp	0.6%-3.2pp	4.5%+0.7pp	3.5%+0.9pp	5.9%+2.5pp	3.8%+5.0pp	3.9%+2.6pp
Return on Equity	3.8%-1.8pp	4.1%-6.1pp	0.8%-7.7pp	6.5%-0.1pp	5.7%+0.6pp	10.2%+4.0pp	8.5%+10.9pp	6.6%+4.4pp
Return on Assets	2.1%-0.7pp	2.2%-2.3pp	0.4%-3.3pp	3.5%+0.5pp	2.7%+0.6pp	4.5%+1.8pp	3.7%+4.8pp	3.0%+2.0pp
Current Ratio	1.890.0x	1.96+0.3x	2.03+0.4x	2.39+0.6x	1.87+0.2x	1.660.0x	1.660.0x	1.76+0.1x
Debt-to-Equity	0.85-0.2x	0.86-0.4x	0.85-0.4x	0.86-0.4x	1.08-0.2x	1.270.0x	1.290.0x	1.22-0.1x
Asset Turnover	0.68-0.1x	0.70-0.1x	0.80-0.2x	0.770.0x	0.770.0x	0.760.0x	0.99+0.2x	0.770.0x
FCF Margin	8.8%+7.3pp	9.1%+5.8pp	3.5%-9.4pp	-5.8%-3.8pp	1.5%-3.2pp	3.3%-2.6pp	12.8%+10.5pp	-2.0%-9.0pp

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
Lifevantage Corporation LFVN	FY2026	$182.6M	$5.1M	2.8%	$73.0M	49/100
FitLife Brands, Inc. FTLF	FY2025	$15.9M	$6.3M	39.7%	$85.2M	55/100
BioHarvest Sciences Inc. BHST	FY2025	$34.5M	-$11.1M	-32.3%	$41.3M	37/100
Hain Celestial Group Inc HAIN	FY2026	$1.4B	-$304.9M	-22.5%	$52.0M	22/100
Beyond Meat, Inc. BYND	FY2025	$275.5M	$219.0M	79.5%	$124.0M	25/100
BRC Inc. BRCC	FY2025	$398.3M	-$11.9M	-3.0%	$143.3M	32/100

Where Lifevantage Corporation Ranks

Frequently Asked Questions

What is Lifevantage Corporation's annual revenue?

Lifevantage Corporation (LFVN) reported $182.6M in total revenue for fiscal year 2026. This represents a -20.1% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Lifevantage Corporation's revenue growing?

Lifevantage Corporation (LFVN) revenue declined by 20.1% year-over-year, from $228.5M to $182.6M in fiscal year 2026.

Is Lifevantage Corporation profitable?

Yes, Lifevantage Corporation (LFVN) reported a net income of $5.1M in fiscal year 2026, with a net profit margin of 2.8%.

What is Lifevantage Corporation's EBITDA?

Lifevantage Corporation (LFVN) had EBITDA of $8.9M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization.

What is Lifevantage Corporation's gross margin?

Lifevantage Corporation (LFVN) had a gross margin of 77.6% in fiscal year 2026, indicating the percentage of revenue retained after direct costs of goods sold.

What is Lifevantage Corporation's operating margin?

Lifevantage Corporation (LFVN) had an operating margin of 3.3% in fiscal year 2026, reflecting the profitability of core business operations before interest and taxes.

What is Lifevantage Corporation's net profit margin?

Lifevantage Corporation (LFVN) had a net profit margin of 2.8% in fiscal year 2026, representing the share of revenue converted into profit after all expenses.

Does Lifevantage Corporation pay dividends?

Yes, Lifevantage Corporation (LFVN) paid $0.18 per share in dividends during fiscal year 2026.

What is Lifevantage Corporation's return on equity (ROE)?

Lifevantage Corporation (LFVN) has a return on equity of 15.1% for fiscal year 2026, measuring how efficiently the company generates profit from shareholder equity.

What is Lifevantage Corporation's free cash flow?

Lifevantage Corporation (LFVN) generated $6.7M in free cash flow during fiscal year 2026. This represents a -36.5% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Lifevantage Corporation's operating cash flow?

Lifevantage Corporation (LFVN) generated $10.2M in operating cash flow during fiscal year 2026, representing cash generated from core business activities.

What are Lifevantage Corporation's total assets?

Lifevantage Corporation (LFVN) had $62.1M in total assets as of fiscal year 2026, including both current and long-term assets.

What are Lifevantage Corporation's capital expenditures?

Lifevantage Corporation (LFVN) invested $3.6M in capital expenditures during fiscal year 2026, funding long-term assets and infrastructure.

How much does Lifevantage Corporation spend on research and development?

Lifevantage Corporation (LFVN) invested $1.0M in research and development during fiscal year 2026.

Does Lifevantage Corporation buy back shares?

Yes, Lifevantage Corporation (LFVN) spent $2.0M on share buybacks during fiscal year 2026, returning capital to shareholders by reducing shares outstanding.

How many shares does Lifevantage Corporation have outstanding?

Lifevantage Corporation (LFVN) had 13M shares outstanding as of fiscal year 2026.

What is Lifevantage Corporation's current ratio?

Lifevantage Corporation (LFVN) had a current ratio of 1.89 as of fiscal year 2026, which is generally considered healthy.

What is Lifevantage Corporation's debt-to-equity ratio?

Lifevantage Corporation (LFVN) had a debt-to-equity ratio of 0.85 as of fiscal year 2026, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Lifevantage Corporation's return on assets (ROA)?

Lifevantage Corporation (LFVN) had a return on assets of 8.2% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.

What is Lifevantage Corporation's P/E ratio?

Lifevantage Corporation (LFVN) trades at 14.4x earnings, its market capitalization divided by net income of $5.1M net income, FY2026. The market capitalization is $73.0M as of Oct 15, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Lifevantage Corporation's price-to-sales ratio?

Lifevantage Corporation (LFVN) trades at 0.4x sales, its market capitalization divided by revenue of $182.6M revenue, FY2026. The market capitalization is $73.0M as of Oct 15, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Lifevantage Corporation's Altman Z-Score?

Lifevantage Corporation (LFVN) has an Altman Z-Score of 2.82, placing it in the Grey Zone (moderate risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Lifevantage Corporation's Piotroski F-Score?

Lifevantage Corporation (LFVN) has a Piotroski F-Score of 5 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Lifevantage Corporation's earnings high quality?

Lifevantage Corporation (LFVN) has an earnings quality ratio of 2.02x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is Lifevantage Corporation?

Lifevantage Corporation (LFVN) scores 49 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.